Literature DB >> 26751394

Structural characterization of a Vatairea macrocarpa lectin in complex with a tumor-associated antigen: A new tool for cancer research.

Bruno L Sousa1, José C Silva-Filho1, Prashant Kumar2, Melissa A Graewert3, Ronniery I Pereira1, Rodrigo M S Cunha4, Kyria S Nascimento1, Gustavo A Bezerra5, Plínio Delatorre6, Kristina Djinovic-Carugo7, Celso S Nagano8, Karl Gruber2, Benildo S Cavada1.   

Abstract

Legume lectins are the most thoroughly studied group of lectins and have been widely linked to many pathological processes. Their use as immunohistochemistry markers for cell profiling and cancer diagnosis have made these molecules important tools for immunological studies and have stimulated the prospection and characterization of new lectins. The crystal structures of a recombinant seed lectin from Vatairea macrocarpa (rVML) and its complexes with GalNAcα1-O-Ser, GalNAc and α-lactose, have been determined at 1.90, 1.97, 2.70 and 1.83Å resolution, respectively. Small angle X-ray scattering and calorimetry assays have confirmed the same pH stable oligomerization pattern and binding profiles proposed for its wild-type counterpart. In silico analyzes have explored the potential of this recombinant lectin as new tool for cancer research through a comparative profile with other legume lectins widely used for cancer diagnosis and prognosis. The results suggest the recognition of specific epitopes exhibited on different cancer cells as a process that relies on the disposition of hydrophobic clusters and charged regions around the lectin carbohydrate-binding site, favouring the anchorage of different groups in the antigen boundaries, highlighting the different potential of each analyzed lectin. In conclusion, the experimental results and comparative analysis show that rVML is as a promising tool for cancer research, able to bind with high affinity specific tumor-associated antigens, highly stable and easily produced.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer research; Crystal structure; Histochemistry; Legume lectin; Tn antigen; Vatairea macrocarpa

Mesh:

Substances:

Year:  2016        PMID: 26751394     DOI: 10.1016/j.biocel.2015.12.016

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth.

Authors:  Jacek Lubkowski; Sarah V Durbin; Mariana C C Silva; David Farnsworth; Jeffrey C Gildersleeve; Maria Luiza V Oliva; Alexander Wlodawer
Journal:  FEBS J       Date:  2017-02-01       Impact factor: 5.542

2.  The Galactose-Binding Lectin Isolated from Vatairea macrocarpa Seeds Enhances the Effect of Antibiotics Against Staphylococcus aureus-Resistant Strain.

Authors:  Valdenice F Santos; Maria S Costa; Fábia F Campina; Renato R Rodrigues; Ana L E Santos; Felipe M Pereira; Karla L R Batista; Rafael C Silva; Raquel O Pereira; Bruno A M Rocha; Henrique D M Coutinho; Claudener S Teixeira
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

3.  Molecular dynamics and binding energy analysis of Vatairea guianensis lectin: a new tool for cancer studies.

Authors:  Benildo Sousa Cavada; Vinicius Jose Silva Osterne; Vanir Reis Pinto-Junior; Luiz Augusto Gomez Souza; Claudia Figueiredo Lossio; Mayara Torquato Lima Silva; Corneville Correia-Neto; Messias Vital Oliveira; Jorge Luis Almeida Correia; Antonio Hadson Bastos Neco; Jorge Luiz Coelho Domingos; Wandemberg Paiva Ferreira; Gil Aquino Farias; Kyria Santiago Nascimento
Journal:  J Mol Model       Date:  2020-01-07       Impact factor: 1.810

4.  Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), by Wisteria floribunda Agglutinin.

Authors:  Omid Haji-Ghassemi; Michel Gilbert; Jenifer Spence; Melissa J Schur; Matthew J Parker; Meredith L Jenkins; John E Burke; Henk van Faassen; N Martin Young; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.